MAP4K

MAP 激酶激酶激酶激酶 (MAP4K) 属于哺乳动物 Ste20 样丝氨酸/苏氨酸激酶家族。据报道,MAP4K 包括 MAP4K1/HPK1、MAP4K2/GCK、MAP4K3/GLK、MAP4K4/HGK、MAP4K5/KHS 和 MAP4K6/MINK,它们通过激活 MAP3K-MAP2K 级联来诱导 JNK 活化。MAP4K 在调节细胞凋亡、细胞存活、细胞自噬和细胞迁移方面发挥重要作用。多项研究报告称,MAP4K 通过 JNK 独立途径参与调节免疫细胞反应。

MAP4K1/HPK1 和 MAP4K4/HGK 在 T 细胞活化和炎症反应中起负面作用。相反,MAP4K3/GLK在T细胞活化和自身免疫反应中起着积极作用。此外,T细胞中MAP4K1的下调和MAP4K3的过表达与人类自身免疫性疾病有关,例如银屑病关节炎、类风湿性关节炎(RA)、成人斯蒂尔病和SLE。

MAP kinase kinase kinase kinases (MAP4Ks) belong to the mammalian Ste20-like family of serine/threonine kinases. MAP4Ks including MAP4K1/HPK1, MAP4K2/GCK, MAP4K3/GLK, MAP4K4/HGK, MAP4K5/KHS, and MAP4K6/MINK have been reported to induce JNK activation through activating the MAP3K-MAP2K cascade. MAP4Ks play important roles in the regulation of cell apoptosis, cell survival, cell autophagy, and cell migration. Several studies reported that MAP4Ks are involved in the regulation of immune-cell responses through JNK-independent pathways.

MAP4K1/HPK1 and MAP4K4/HGK play negative roles in T-cell activation and inflammatory responses. In contrast, MAP4K3/GLK plays a positive role in T-cell activation and autoimmune responses. Moreover, MAP4K1 downregulation and MAP4K3 overexpression in T cells are involved in human autoimmune diseases such as psoriatic arthritis, rheumatoid arthritis (RA), adult-onset Still’s disease, and SLE.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
NCB-0970

NCB-0970 是 NCB-0846 (MS-Y33957) 的阴性对照,而 NCB-0846 是一种口服有效的 Wnt 选择性抑制剂,可通过抑制 Traf2 和 Nck 相互作用激酶 (TNIK)(IC50 为 21 nM)以及抑制 SMAD2/3 磷酸化和核转位来阻断 TGF-β 信号通路。

2749881-54-5
Control
98.81%
NCB-0970

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础